- Home
- Publications
- Publication Search
- Publication Details
Title
Fatty Liver Disease: Enter the Metabolic Era
Authors
Keywords
-
Journal
Current HIV/AIDS Reports
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-26
DOI
10.1007/s11904-023-00669-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis
- (2023) Markos Kalligeros et al. Clinical Gastroenterology and Hepatology
- AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- (2023) Mary E. Rinella et al. HEPATOLOGY
- Risk of adverse cardiovascular outcomes among people with HIV and nonalcoholic fatty liver disease
- (2023) Arunkumar Krishnan et al. AIDS
- Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease
- (2023) Cynthia L. Hsu et al. DIGESTIVE DISEASES AND SCIENCES
- Letter to the editor: People living with HIV and NAFLD: A population left behind in the global effort for liver fibrosis screening?
- (2023) Giada Sebastiani et al. HEPATOLOGY
- Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter study
- (2023) Samer Gawrieh et al. HEPATOLOGY
- Non-alcoholic fatty liver disease is not associated with impairment in health-related quality of life in virally suppressed persons with human immune deficiency virus
- (2023) Samer Gawrieh et al. PLoS One
- CD4+ T cells expressing CX3CR1, GPR56, with variable CD57 are associated with cardiometabolic diseases in persons with HIV
- (2023) Celestine N. Wanjalla et al. Frontiers in Immunology
- Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis With Liver Fibrosis as Predictors of New-Onset Diabetes Mellitus in People Living With Human Immunodeficiency Virus: A Longitudinal Cohort Study
- (2023) Win Min Han et al. CLINICAL INFECTIOUS DISEASES
- Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease
- (2023) Daniel Bradshaw et al. PLoS One
- Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV
- (2022) Itzíar Carrasco et al. AIDS
- Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct‐acting antiviral therapies
- (2022) Shingo Shimada et al. Transplant Infectious Disease
- Impact of Combined Antiretroviral Therapy on Metabolic Syndrome Components in Adult People Living with HIV: A Literature Review
- (2022) Mariusz Sapuła et al. Viruses-Basel
- Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study
- (2022) Maud Lemoine et al. Clinical Gastroenterology and Hepatology
- HIV is associated with elevated FibroScan-AST (FAST) score
- (2022) Jennifer C. Price et al. CLINICAL INFECTIOUS DISEASES
- Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
- (2022) Kylynda C. Bauer et al. GASTROENTEROLOGY
- “Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV”
- (2022) Adriana Cervo et al. HIV MEDICINE
- Multisite prospective Liver Disease and Reproductive Ageing (LIVRA) study in US women living with and without HIV
- (2022) Jennifer Price et al. BMJ Open
- Diagnosis of liver fibrosis in ageing patients with HIV at risk for non-alcoholic fatty liver disease in Italy and Canada: assessment of a two-tier pathway
- (2022) Giada Sebastiani et al. Lancet HIV
- Integrase Inhibitors Partially Restore Bacterial Translocation, Inflammation and Gut Permeability Induced by HIV Infection: Impact on Gut Microbiota
- (2022) Pablo Villoslada-Blanco et al. Infectious Diseases and Therapy
- Prevalence and risk factors of non-alcoholic steatohepatitis with significant fibrosis in people living with HIV
- (2022) Maurice Michel et al. AIDS
- Prevalence and Risk Factors for Hepatic Steatosis in Children With Perinatal HIV on Early Antiretroviral Therapy Compared to HIV-Exposed Uninfected and HIV-Unexposed Children
- (2022) Penelope C. Rose et al. Frontiers in Pediatrics
- Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens
- (2022) C Busca et al. Open Forum Infectious Diseases
- Liver Inflammation Is Common and Linked to Metabolic Derangements in Persons With Treated Human Immunodeficiency Virus (HIV)
- (2022) Kara W Chew et al. CLINICAL INFECTIOUS DISEASES
- Genetic variants associated with steatohepatitis and liver fibrosis in HIV-infected patients with NAFLD
- (2022) C. Busca et al. Frontiers in Pharmacology
- Factors associated with liver steatosis in people living with HIV on contemporary antiretroviral therapy
- (2022) Carlotta Riebensahm et al. Open Forum Infectious Diseases
- Proteomic Analysis of Hepatic Fibrosis in Human Immunodeficiency Virus–Associated Nonalcoholic Fatty Liver Disease Demonstrates Up-regulation of Immune Response and Tissue Repair Pathways
- (2022) Lindsay T Fourman et al. JOURNAL OF INFECTIOUS DISEASES
- Hepatic steatosis associated with exposure to elvitegravir and raltegravir
- (2021) Ditte Marie Kirkegaard-Klitbo et al. CLINICAL INFECTIOUS DISEASES
- The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging
- (2021) Madison Schank et al. Cells
- Food Insecurity and Lipid Profile Abnormalities Are Associated with an Increased Risk of Nonalcoholic Fatty Liver Disease (NAFLD): A Case–Control Study
- (2021) Helda Tutunchi et al. ECOLOGY OF FOOD AND NUTRITION
- Diagnostic value of serological biomarkers for detection of non‐alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV
- (2021) C Yanavich et al. HIV MEDICINE
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-Infection and Nonalcoholic Fatty Liver Disease
- (2021) Takara L Stanley et al. CLINICAL INFECTIOUS DISEASES
- Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial
- (2021) Pamela S Douglas et al. CLINICAL INFECTIOUS DISEASES
- Telemedicine as a tool for dietary intervention in NAFLD-HIV patients during the COVID-19 lockdown: A randomized controlled trial
- (2021) Sara Policarpo et al. Clinical Nutrition ESPEN
- HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV
- (2021) Christine M. Durand et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Presumed Nonalcoholic Fatty Liver Disease Among Medicare Beneficiaries With HIV, 2006–2016
- (2020) James M Paik et al. Open Forum Infectious Diseases
- Prevalence, predictors and severity of lean non-alcoholic fatty liver disease in HIV-infected patients
- (2020) Adriana Cervo et al. CLINICAL INFECTIOUS DISEASES
- Clinical Predictors of Liver Fibrosis Presence and Progression in HIV-Associated NAFLD
- (2020) Lindsay T Fourman et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease in Persons with HIV
- (2020) Alyson Kaplan et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection
- (2020) Thomas Krahn et al. JOURNAL OF INFECTIOUS DISEASES
- Prevalence and Risk Factors of Moderate to Severe Hepatic Steatosis in HIV Infection: The Copenhagen Co-Morbidity Liver Study
- (2020) Ditte Marie Kirkegaard-Klitbo et al. JOURNAL OF INFECTIOUS DISEASES
- Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
- (2020) Kassem Bourgi et al. Journal of the International AIDS Society
- Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial
- (2020) Adrian Curran et al. Journal of Clinical Medicine
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV
- (2020) Jovana Milic et al. AIDS
- Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT alone
- (2020) Daniel Bradshaw et al. BMJ Open
- Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD
- (2020) Lindsay T. Fourman et al. JCI Insight
- Fatty Liver Disease in a Prospective North American Cohort of Adults with HIV and Hepatitis B Coinfection
- (2020) Mandana Khalili et al. CLINICAL INFECTIOUS DISEASES
- Increased Body Mass Index and Type 2 Diabetes Are the Main Predictors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in Liver Biopsies of Patients With Human Immunodeficiency Virus Monoinfection
- (2020) James B Maurice et al. CLINICAL INFECTIOUS DISEASES
- Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard
- (2020) Veeral H Ajmera et al. CLINICAL INFECTIOUS DISEASES
- Pro-Inflammatory Interleukin-18 is Associated with Hepatic Steatosis and Elevated Liver Enzymes in People with HIV Monoinfection
- (2020) Jae H. Sim et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Food insecurity is associated with magnetic resonance–determined nonalcoholic fatty liver and liver fibrosis in low-income, middle-aged adults with and without HIV
- (2020) Javier A Tamargo et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Monocyte-Macrophage activation is associated with NAFLD and liver fibrosis in HIV mono-infection independently of the gut microbiome and bacterial translocation
- (2019) James B. Maurice et al. AIDS
- Fibroblast Growth Factor 21 is independently associated with severe hepatic steatosis in non‐obese HIV ‐infected patients
- (2019) Michael Praktiknjo et al. LIVER INTERNATIONAL
- Increased Prevalence of Hepatic Steatosis in Young Adults with Life-long HIV
- (2019) Julia A Aepfelbacher et al. JOURNAL OF INFECTIOUS DISEASES
- Novel MRI assessment of treatment response in HIV ‐associated NAFLD : a randomized trial of an SCD 1 inhibitor ( ARRIVE Trial)
- (2019) Veeral H. Ajmera et al. HEPATOLOGY
- Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease
- (2019) Leonardo Calza et al. Infectious Diseases
- Elevated fatty liver index as a risk factor for all‐cause mortality in HIV‐HCV co‐infected patients (ANRS CO13 HEPAVIH cohort study)
- (2019) Tangui Barré et al. HEPATOLOGY
- Vitamin E is an effective treatment for nonalcoholic steatohepatitis in HIV mono-infected patients
- (2019) Giada Sebastiani et al. AIDS
- Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV ‐monoinfected patients
- (2019) G Sebastiani et al. HIV MEDICINE
- Sex hormone-binding globulin levels are inversely associated with nonalcoholic fatty liver disease in HIV-infected and –uninfected men
- (2019) Jennifer C Price et al. Open Forum Infectious Diseases
- Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
- (2019) Takara L Stanley et al. Lancet HIV
- Lower Concentrations of Circulating Medium and Long-Chain Acylcarnitines Characterize Insulin Resistance in Persons with HIV
- (2018) Samuel S. Bailin et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients
- (2018) Maria Patrizia Carrieri et al. JOURNAL OF HEPATOLOGY
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non-alcoholic fatty liver disease
- (2018) Chloe S. Chaudhury et al. LIVER INTERNATIONAL
- Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection
- (2018) Amine Benmassaoud et al. PLoS One
- CD28null pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death
- (2018) Alejandra Pera et al. Theranostics
- Diagnostic accuracy of noninvasive markers of steatosis, NASH and liver fibrosis in HIV-monoinfected individuals at-risk of non-alcoholic fatty liver disease (NAFLD)
- (2018) Maud Lemoine et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Fat mass and obesity-associated gene variations are related to fatty liver disease in HIV-infected patients
- (2017) R Núñez-Torres et al. HIV MEDICINE
- Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients
- (2017) Maria Patrizia Carrieri et al. JOURNAL OF HEPATOLOGY
- Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis
- (2017) Thomas Pembroke et al. JOURNAL OF HEPATOLOGY
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Expansions of Cytotoxic CD4+CD28− T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection
- (2017) Iain Broadley et al. Frontiers in Immunology
- Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients
- (2016) Élise Vuille-Lessard et al. AIDS
- Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection
- (2016) Rosa Lombardi et al. DIGESTIVE AND LIVER DISEASE
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- A Meta-Analysis of the Metabolic Syndrome Prevalence in the Global HIV-Infected Population
- (2016) Kim A. Nguyen et al. PLoS One
- The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients
- (2016) Rocío Núñez-Torres et al. PLoS One
- Impact of genetic polymorphisms associated with nonalcoholic fatty liver disease on HIV-infected individuals
- (2015) Juan Macias et al. AIDS
- Validation of Noninvasive Methods for Detecting Hepatic Steatosis in Patients With Human Immunodeficiency Virus Infection
- (2015) M. Shadab Siddiqui et al. Clinical Gastroenterology and Hepatology
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study
- (2014) I. Vodkin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Risk Factors for Fatty Liver in the Multicenter AIDS Cohort Study
- (2014) Jennifer C Price et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors
- (2013) Edana Cassol et al. BMC INFECTIOUS DISEASES
- Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13)
- (2012) M. Patrizia Carrieri et al. HEPATOLOGY
- Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons*
- (2011) NF Crum-Cianflone et al. HIV MEDICINE
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Nonalcoholic Fatty Liver Disease Among HIV-Infected Persons
- (2009) Nancy Crum-Cianflone et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Food insecurity and HIV/AIDS: Current knowledge, gaps, and research priorities
- (2009) Aranka Anema et al. Current HIV/AIDS Reports
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now